Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03711227 · ClinicalTrials.gov registry record
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
A clinical trial of Pneumonia, sponsored by Corewell Health South.
- Completed
- Registry status
- 185
- Enrollment target
- 1
- Study location
NCT03711227 is a study of Pneumonia that has completed, run by Corewell Health South. The registered enrollment target is 185 participants, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03711227, a study of Pneumonia, has completed, sponsored by Corewell Health South.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
- 1
- Study location
Study Summary
Procalcitonin levels checked initially and at 24 hours will correlate with disease severity, morbidity, and mortality. Patients who have a higher procalcitonin level initially and at 24 hours will likely have higher qSOFA scores, longer lengths of stay, longer duration of antibiotics and higher 30 day mortality rates.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Procalcitonin lab test
Study Locations (1)
Michigan
- Lakeland Regional Healthcare - Saint Joseph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2018-07-17 |
| Est. Completion | 2019-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03711227
The ClinicalTrials.gov registry entry for NCT03711227 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (96% lower). The listed sponsor is Corewell Health South, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which Procalcitonin lab test is the first listed.
NCT03711227 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03711227 about?
NCT03711227 is a clinical study titled "Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia". Procalcitonin levels checked initially and at 24 hours will correlate with disease severity, morbidity, and mortality. Patients who have a higher procalcitonin level initially and at 24 hours will likely have higher qSOFA scores, longer lengths of stay, longer duration of antibiotics and higher 30 d...
What is the current status of trial NCT03711227?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2018-07-17. Estimated completion is 2019-08-01.
What conditions does trial NCT03711227 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT03711227?
The interventions under investigation include: Procalcitonin lab test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03711227?
This trial is sponsored by Corewell Health South, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03711227 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
RECRUITING
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.